Taylor Coe-Eisenberg|Taylor D. Coe-Eisenberg

Taylor Coe-Eisenberg|Taylor D. Coe-Eisenberg

Oregon Health & Science University - Portland / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5467581
person_outline Taylor Coe-Eisenberg|Taylor D. Coe-Eisenberg's MOST POPULAR ARTICLES
1-) Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trialsLA Marcath, TD Coe, EK Hoylman, BG Redman, DL HertzBMC cancer 18, 1-8, 2018382018
2-) Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoringTD Coe-Eisenberg, AJ Perissinotti, BL Marini, KM Pettit, DL Bixby, ...Annals of Hematology 102 (11), 3133-3141, 202322023
3-) Improvement initiative to develop and implement a tool for detecting drug-drug interactions during oncology clinical trial enrollment eligibility screeningLA Marcath, TD Coe, F Shakeel, E Reynolds, M Bayuk, S Haas, ...Journal of patient safety 17 (1), e28-e34, 202122021
4-) Development of a drug-drug interaction screening tool for oncology clinical trial enrollment.LA Marcath, TD Coe, BG Redman, DL HertzJournal of Clinical Oncology 36 (30_suppl), 315-315, 201812018
5-) Prevalence of clinically relevant drug-drug interactions in patients enrolled in NCTN clinical trials.LA Marcath, TD Coe, EK Hoylman, BG Redman, DL HertzJournal of Clinical Oncology 36 (15_suppl), e18819-e18819, 20182018